550-83-4

550-83-4 structure

Name: Propoxycaine (hydrochloride)
Chemical Name: 2-(diethylamino)ethyl 4-amino-2-propoxybenzoate,hydrochloride
CAS Number: 550-83-4
Molecular Formula: C₁₆H₂₇ClN₂O₃
Molecular Weight: 330.85000
Catalog: Signaling Pathways Membrane Transporter/Ion Channel Sodium Channel
Create Date: 2017-10-09 22:15:48
Modify Date: 2024-01-11 16:13:39
Propoxycaine hydrochloride is the hydrochloride salt form of Propoxycaine, a para-aminobenzoic acid ester with local anesthetic activity.Target: sodium channelPropoxycaine binds to and inhibits voltage-gated sodium channels, thereby inhibiting the ionic flux required for the initiation and conduction of impulses. This results in a loss of sensation.

Name	2-(diethylamino)ethyl 4-amino-2-propoxybenzoate,hydrochloride
Synonyms	Pravocaine hydrochloride EINECS 208-988-7 WIN 3459 Propoxycaine HCl Ravocaine hydrochloride Blockain 4-Amino-2-propoxybenzoic acid 2-(diethylamino)ethyl ester hydrochloride BENZOIC ACID,4-AMINO-2-PROPOXY-,2-(DIETHYLAMINO)ETHYL ESTER,MONOHYDROCHLORIDE Propoxycaine Hyrochloride Propoxycaine hydrochloride Propoxycaine (hydrochloride)

Description	Propoxycaine hydrochloride is the hydrochloride salt form of Propoxycaine, a para-aminobenzoic acid ester with local anesthetic activity.Target: sodium channelPropoxycaine binds to and inhibits voltage-gated sodium channels, thereby inhibiting the ionic flux required for the initiation and conduction of impulses. This results in a loss of sensation.
Related Catalog	Signaling Pathways >> Membrane Transporter/Ion Channel >> Sodium Channel Research Areas >> Neurological Disease

CHEMICAL NAME :: Benzoic acid, 4-amino-2-propoxy-, 2-(diethylamino)ethyl ester, monohydrochloride

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: APFRAD Annales Pharmaceutiques Francaises. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1943- Volume(issue)/page/year: 40,133,1982

TOXIC EFFECTS :: Behavioral - convulsions or effect on seizure threshold Vascular - BP lowering not characterized in autonomic section Lungs, Thorax, or Respiration - other changes

REFERENCE :: JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 123,269,1958

RIDADR	UN 2811 6.1 / PGIII